Document:

EXHIBIT 10.1

 

WARRANT PURCHASE AGREEMENT

 

AGREEMENT, dated as of
November 14, 2016 (this “Agreement”), between Hillair Capital Investments, L.P. (“Hillair”
or the “Seller”), whose address is c/o Ellenoff Grossman & Schole, LLP, 1345 Avenue of the Americas, New
York, New York 10105, and First Choice Healthcare Solutions, Inc. (“FCHS” or the “Purchaser”),
Delaware Corporation.

 

W I T N E S S E T H:

 

WHEREAS, FCHS granted Hillair
a warrant to subscribe for and purchase from FCHS up to 2,320,000 shares of FCHS common stock (the “Warrant”),
pursuant to a Common Stock Purchase Warrant Agreement between FCHS and Hillair, dated as of November 8, 2013 (the “Warrant
Agreement”); and

 

WHEREAS, the Seller desires
to sell to the Purchaser, and the Purchaser desires to purchase from the Seller, the Warrant;

 

NOW, THEREFORE, it is hereby
agreed as follows:

 

1.            Sale and Purchase
of the Warrant. On the basis of the representations, warranties and agreements herein contained and subject to the terms and
conditions hereof, the Seller hereby agrees to sell to the Purchaser, and the Purchaser agrees to purchase from the Seller, the
Warrant.

 

2.            The Closing.
The closing (the “Closing”) of the purchase and sale of the Warrant shall take place at the offices of Schnader
Harrison Segal & Lewis, LLP, 140 Broadway, Suite 3100, New York, NY 10005 on or about November 15, 2016, or at such other place
or time as the parties shall mutually agree (the “Closing Date”). At the Closing, the Seller shall deliver to
the Purchaser the original copy of the Warrant Agreement against payment of the Purchase Price (as defined in Section 3 hereof)
therefor.

 

3.            Purchase Price.
The purchase price for the Warrant is $600,000 (the “Purchase Price”), which shall be paid by wire transfer,
immediately available funds. Each party covenants and agrees that there will be no broker or other fees payable to a third party
in connection with the transactions contemplated hereunder.

 

4.            Representations
and Warranties of the Seller. The Seller represents and warrants to the Purchaser that:

 

(a)          Seller has the full
right, power and authority to enter into this Agreement and to sell the Warrant to be sold pursuant hereto, and upon payment thereof
as provided herein, the Purchaser will acquire good and valid title thereto, free and clear of any security interests, liens, encumbrances,
equities or claims;

 

(b)          No prior authorization,
consent or approval of any governmental body, authority or agency is necessary to the validity of the sale of the Warrant by Seller
on the terms and conditions and for the consideration herein set forth;

 

     

     

    

 

(c)          Seller is the (i)
sole owner of, and has good and valid title to, the Warrant and (ii) has been the sole record and beneficial owner of the Warrant,
free and clear of all liens and free and clear of all transfer taxes in respect thereof, for a period of at least six months; and

 

(d)          Seller is not and
has never been an “affiliate” of the FCHS, as defined in Rule 405 under the Securities Act of 1933, as amended (the
“Securities Act”).

 

5.            Representations
and Warranties of the Purchaser. The Purchaser represents and warrants to the Seller that:

 

(a)          Purchaser has the
full right, power and authority to enter into this Agreement and to purchase the Warrant pursuant hereto;

 

(b)          No prior authorization,
consent or approval of any governmental body, authority or agency is necessary to the validity of the purchase by the Purchaser
of the Warrant on the terms and conditions and for the consideration herein set forth.

 

6.            Binding Effect.
The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their successors, assigns,
heirs, executors and administrators.

 

7.            Survival of Representations.
All representations, warranties and agreements made by the parties in this Agreement or made in writing pursuant hereto, or in
any certificate delivered pursuant hereto shall survive the consummation of the transactions contemplated hereby, regardless of
any investigation at any time made by or on behalf of any of the parties.

 

8.            Modification.
This Agreement sets forth the entire agreement of the parties with respect to the subject matte hereof, supersedes all existing
agreements among them concerning such subject matter and may be modified only by a written instrument duly executed by the party
to be charged.

 

9.            Notices. Any
notice or other communication required or permitted to be given hereunder shall be in writing and shall be mailed by certified
mail, return receipt requested, or delivered against receipt of the party to whom it is to be given at the address of such party
set forth in the preamble to this Agreement (or to such address as the party shall have furnished in writing in accordance with
the provisions of this Section 9). Any notice or other communication given by certified mail shall be deemed given at the time
of certification thereof, except for a notice changing a party’s address which shall be deemed given at the time of receipt
thereof.

 

10.          Severability.
If any provision of this Agreement is invalid, illegal or unenforceable, the balance of this Agreement shall remain in effect,
and if any provision is inapplicable to any person or circumstance, it shall nevertheless remain applicable to all other persons
and circumstance.

 

11.         No Reliance
on Other Parties. The Seller has carefully reviewed the public filings of FCHS with the Securities and Exchange Commission,
and such other information that Seller and Seller’s advisers deem necessary to decide whether to enter into the transaction
contemplated under this Agreement. The Seller has made its own decision to consummate the transaction contemplated under this Agreement
based on its own independent review and consultations with such investment, legal, tax, accounting and other advisers as it deemed
necessary. 

 

    2 

     

    

 

12.          Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to
the conflict of laws.

 

13.          Counterparts.
This Agreement may be executed in any number of counterparts, including without limitation via .pdf, facsimile or other electronic
means, each of which shall be an original but all of which together shall constitute one and the same instrument. This Agreement
shall become effective at such time as counterparts thereof have been executed by each of the parties and it shall not be a condition
to its effectiveness that each of the parties has executed the same counterpart.

 

(continued on signature page)

 

    3 

     

    

 

IN WITNESS WHEREOF, the parties
have caused this Warrant Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.

 

	Hillair Capital Investments, L.P.	 	First Choice Healthcare Solutions, Inc.
	 	 	 	 	 
	By:	/s Scott Kaufman	 	By:	/s Chris Romandetti
	Name:	Scott Kaufman	 	Name:	Chris Romandetti
	Title:	Managing Partner	 	Title:	President/CEO
	 	 	 	 	 
	Address for Notice:	 	Address for Notice:
	 	 	 	 	 
	c/o Ellenoff Grossman & Schole LLP
 1345 Avenue of the Americas
 New York, New York 10105
 Attn: Robert F. Charron, Esq.	 	First Choice Healthcare Solutions, Inc.
 709 S. Harbor City Boulevard, Suite 250
 Melbourne, Florida 32901
 Attention: Chris Romandetti, President

 

 

 

[Remainder of the Page Intentionally Left
Blank]

 

 

 

4ex10a.htm

Exhibit (10)(a)

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 30 to the 1933 Act Registration Statement (Form N-4 No. 333-145531) and Amendment No. 378 to the 1940 Act Registration Statement (Form N-4 No. 811-09763), and to the use therein of our reports dated (a) March 31, 2016, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 12, 2016, with respect to the financial statements of Lincoln New York Account N for Variable Annuities for the interests in a separate account under individual flexible payment deferred variable annuity contracts.

/s/ Ernst & Young LLP

 

Philadelphia, Pennsylvania

November 16, 2016ex10a.htm

Exhibit (10)(a)

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 4 to the 1933 Act Registration Statement (Form N-4 No. 333-193274) and Amendment No. 536 to the 1940 Act Registration Statement (Form N-4 No. 811-08517), and to the use therein of our reports dated (a) March 31, 2016, with respect to the consolidated financial statements of The Lincoln National Life Insurance Company and (b) April 12, 2016, with respect to the financial statements of Lincoln Life Variable Annuity Account N for the interests in a separate account under individual flexible payment deferred variable annuity contracts.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania

November 16, 2016ex10a.htm

Exhibit (10)(a)

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 10 to the 1933 Act Registration Statement (Form N-4 No. 333-181617) and Amendment No. 302 to the 1940 Act Registration Statement (Form N-4 No. 811-08441), and to the use therein of our reports dated (a) March 31 2016, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 12, 2016, with respect to the financial statements of Lincoln Life & Annuity Variable Annuity Account H for the interests in a separate account under individual flexible payment deferred variable annuity contracts.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania

November 16, 2016

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]